PUBLISHED : 16 AUG 2023 AT 09:50 1
In recent years, the ASEAN market has witnessed the rapid expansion of Thai
Kratom, spurred by groundbreaking health innovations. Spearheaded by Dr.
Kratom Bio, this initiative has underscored the immense potential of the Thai
herbal industry within the region.
Dr. Kratom Bio unveiled these pioneering innovations in Malaysia, effectively
showcasing the transformative capabilities of Kratom. The grand stage for this
revelation was the “4th International Integrative Medicine Conference &
Inaugural Asian Kratom Congress,” held at the prestigious Majestic Hotel
Kuala Lumpur on August 12th and 13th, 2023. This remarkable event marked
the harmonious collaboration between Dr. Kratom Bio, the Malaysian
government, eminent scientists, leading universities, and the Association of
Integrative Medicine Malaysia (AIMM).
The genesis of Dr. Kratom Bio can be traced back to its inception under the
umbrella of Dr. CBD, a company founded by experts proficient in cannabis
and Kratom extraction and production. In collaboration with Mr. Duncan
MacRae, the visionary behind Kratomade.com and a pioneering Mitragynine
extraction expert, Kratomade products were introduced. This visionary
endeavour aimed at crafting unparalleled goods designed to elevate
consumer well-being by merging medical-grade Kratom extracts with
traditional Thai healing wisdom. The ultimate goal is to share this
amalgamation of knowledge and resources on a global scale.
The distinguished presence of Malaysia’s Deputy Prime Minister, YAB Dato’
Sri Haji Fadillah bin Haji Yusef, graced the international scientific conference
as its Chairman. During the inaugural ceremony, he eloquently stated:
“I am delighted to witness the remarkable strides taken in promoting
Integrative Medicine as a holistic approach to comprehensive health and
wellness. The Inaugural Asian Kratom Congress, a vital component of the 4th
International Integrative Medicine Conference, provides Malaysia a golden
opportunity to showcase its leadership in the realm of Medical Kratom.”
The Malaysian government, acutely aware of the medicinal potential
harboured by Kratom plants, is actively exploring controlled cultivation and
production avenues. With a staggering estimated global user base of 230
million, the Kratom industry’s potential to achieve a valuation of USD 16
billion by 2025 is substantial. This juncture presents Malaysian farmers with a
transformative prospect for their livelihoods.
The conference serves as a forum to strategize the Kratom Industry’s
positioning, ensuring Malaysia capitalises on the benefits of this lucrative cash
crop. By convening international experts, the Ministry of Plantation and
Commodities can glean insights to propel Malaysia into a pioneering role
within the industry. The principles of Integrative Medicine beautifully align
with the ‘Malaysia Madani’ concept, rooted in sustainability, prosperity,
innovation, respect, trust, and compassion. The Deputy Prime Minister
expressed optimism that the conference would foster mature discussions and
pave the way for effective actions that contribute to the nation’s prosperity.
The Association of Integrative Medicine Malaysia (AIMM), a constant
trailblazer in the latest advancements, was lauded for hosting such intellectual
discourse, which fortifies an evidence-based foundation for growth.
In conclusion, the successful launch of the Inaugural Asian Kratom Congress
and the 4th International Integrative Medicine Conference served as a
testament to AIMM’s and the organisers’ dedication in showcasing Malaysia’s
excellence and accomplishments on a global stage.
Dr. Kratom Bio’s ambitious mission involves expanding its Kratom business
throughout the ASEAN region. This intention was publicly declared during
the aforementioned scientific conference in Malaysia. Mr. Pornchai
Padmindra, CEO & Founder of Dr. CBD and Dr. Kratom Bio, passionately
“Our ongoing expansion of the kratom business for health-focused objectives
within the ASEAN realm commences with Thailand and Malaysia. We
recognise our shared historical and resource-based connections with
Malaysia. Dr. Kratom Bio’s collaborative efforts extend closely to the Malaysian
government and other stakeholders, encompassing scientific collectives,
universities, and cultivators.
Central to our ethos is the pride we derive from our trailblazing innovations,
enriching the populace with secure healthcare alternatives and solutions.
Notably, Dr. Kratom Bio stands as the pioneering Asian entity to forge deep
partnerships with distinguished professionals and
leaders across Europe and America. Noteworthy among these collaborations
is our alliance with the globally acclaimed figure, Mr. Duncan MacRae. This
collective thrust fuels our pursuits in conceiving, researching, and
implementing healthcare solutions tethered to kratom extracts, underscored
by an unwavering emphasis on pharmacological research.
Our unwavering commitment is anchored in scientific exploration, facilitating
the creation of high-quality healthcare solutions for both patients and healthconscious
individuals. This commitment manifests through our distinctive
product brands, Mitra G and S.tamina, poised for international market
exportation, commencing in 2024.”
Dr. Kratom Bio proudly unveils two distinct product brands, meticulously
tailored to cater to the diverse needs of consumers:
Mitra G: Synthesizing Mitragynine extracted from Kratom with the wisdom of
Thai herbs, these products originate from the traditional knowledge of Thai
Medicine. Their purpose lies in healing and medicinal applications, drawing
on the indigenous heritage of Traditional Thai Medicine.
S.tamina: Harnessing Mitragynine’s essence, this brand offers a versatile array
of products designed for effortless consumption, including lozenges, instant
powder, effervescent tablets, jellies, and more. S.tamina serves as a caffeinefree
everyday companion, revitalising both mind and body.
Dr. Kratom Bio occupies a distinct niche as a specialised enterprise focused
on the extraction and production of premium-grade medical Kratom products.
The journey commences with rigorous research before embarking on the
development phase. Advanced technology is harnessed to safeguard
consistency, safety, and efficacy at every juncture, culminating in the final endproduct.
Each of our meticulously extracted offerings adheres to medicalgrade
standards, unequivocally free from pesticides and chemical
Prominent within the portfolio, Mitra G and S.tamina brands, stand as
exemplars of meticulous safety measures, further underscoring our
commitment to quality excellence, social responsibility, and the advancement
of a globally trusted brand reputation.